Citation Impact
Citing Papers
Intra‐ and inter‐tumor heterogeneity in a vemurafenib‐resistant melanoma patient and derived xenografts
2015
A MicroRNA Screen Identifies the Wnt Signaling Pathway as a Regulator of the Interferon Response during Flavivirus Infection
2017
Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations
2013 Standout
VIRTUS: a pipeline for comprehensive virus analysis from conventional RNA-seq data
2020 StandoutNobel
Understanding Command and Control
2006 Standout
Infrared molecular fingerprinting of blood-based liquid biopsies for the detection of cancer
2021 StandoutNobel
A mechanism of resistance to gefitinib mediated by cellular reprogramming and the acquisition of an FGF2-FGFR1 autocrine growth loop
2013
What Is Trophoblast? A Combination of Criteria Define Human First-Trimester Trophoblast
2016
Interferon-γ regulates cellular metabolism and mRNA translation to potentiate macrophage activation
2015 StandoutNobel
Cancer Evolution and the Limits of Predictability in Precision Cancer Medicine
2016
Cancer heterogeneity: implications for targeted therapeutics
2013
A view on drug resistance in cancer
2019 StandoutNature
A river model to map convergent cancer evolution and guide therapy in RCC
2015
Pseudomonas aeruginosa cleaves the decoding center of Caenorhabditis elegans ribosomes
2020 StandoutNobel
Induced Pluripotent Stem Cells: Past, Present, and Future
2012 StandoutNobel
Clinical activity of afatinib in patients with advanced non-small-cell lung cancer harbouring uncommon EGFR mutations: a combined post-hoc analysis of LUX-Lung 2, LUX-Lung 3, and LUX-Lung 6
2015
The biology and management of non-small cell lung cancer
2018 StandoutNature
Direct Lineage Conversion of Terminally Differentiated Hepatocytes to Functional Neurons
2011 StandoutNobel
First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer
2014 Standout
Plasticity of tumour and immune cells: a source of heterogeneity and a cause for therapy resistance?
2013
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2016 Standout
Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future
2017 Standout
Cancer drug resistance: an evolving paradigm
2013 Standout
Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial
2014 Standout
Osimertinib or Platinum–Pemetrexed in EGFR T790M–Positive Lung Cancer
2016 Standout
Cancer stem cells revisited
2017 Standout
Incomplete DNA methylation underlies a transcriptional memory of somatic cells in human iPS cells
2011
RAS-targeted therapies: is the undruggable drugged?
2020
Machine Learning methods for Quantitative Radiomic Biomarkers
2015 Standout
Genetics and biomarkers in personalisation of lung cancer treatment
2013
Lung cancer: current therapies and new targeted treatments
2016 Standout
Tinkering with Translation: Protein Synthesis in Virus-Infected Cells
2012
SciClone: Inferring Clonal Architecture and Tracking the Spatial and Temporal Patterns of Tumor Evolution
2014
Molecular mechanisms of resistance in epidermal growth factor receptor-mutant lung adenocarcinomas
2014
Screening for Germline EGFR T790M Mutations Through Lung Cancer Genotyping
2012
Intrinsic Immunity Shapes Viral Resistance of Stem Cells
2017 StandoutNobel
Regulation of the C. elegans molt by pqn-47
2011 StandoutNobel
A Broad RNA Virus Survey Reveals Both miRNA Dependence and Functional Sequestration
2016 StandoutNobel
MicroRNA Expression Profiling of Oligodendrocyte Differentiation from Human Embryonic Stem Cells
2010
EMT: 2016
2016 Standout
The causes and consequences of genetic heterogeneity in cancer evolution
2013 StandoutNature
PROTAC targeted protein degraders: the past is prologue
2022 Standout
Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages
2020 Standout
Regulation of type I interferon responses
2013 Standout
Ten Strategies of Interferon Evasion by Viruses
2017
An RNA-centric dissection of host complexes controlling flavivirus infection
2019 StandoutNobel
Epigenetic factors influencing resistance to nuclear reprogramming
2011 StandoutNobel
Host Translation at the Nexus of Infection and Immunity
2012
The PI3K Pathway in Human Disease
2017 Standout
Poor response to erlotinib in patients with tumors containing baseline EGFR T790M mutations found by routine clinical molecular testing
2014
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2018 Standout
Renal cell carcinoma
2017 Standout
Spatiotemporal T790M Heterogeneity in Individual Patients with EGFR-Mutant Non–Small-Cell Lung Cancer after Acquired Resistance to EGFR-TKI
2015
Tumour heterogeneity and resistance to cancer therapies
2017 Standout
Viral subversion of the host protein synthesis machinery
2011
AZD9291 in EGFR Inhibitor–Resistant Non–Small-Cell Lung Cancer
2015 Standout
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
2020 Standout
Transcriptional response to hepatitis C virus infection and interferon‐alpha treatment in the human liver
2017
The Fibroblast Growth Factor signaling pathway
2015 Standout
Characterization of Novel Splice Variants of Zinc Finger Antiviral Protein (ZAP)
2019 StandoutNobel
Orthogonal Design of Experiments for Engineering of Lipid Nanoparticles for mRNA Delivery to the Placenta
2023 StandoutNobel
Replication of Many Human Viruses Is Refractory to Inhibition by Endogenous Cellular MicroRNAs
2014
The MAPK pathway across different malignancies: A new perspective
2014 Standout
TIMER2.0 for analysis of tumor-infiltrating immune cells
2020 Standout
Intratumor Heterogeneity: Seeing the Wood for the Trees
2012
Targeting ALK: Precision Medicine Takes on Drug Resistance
2017
Epithelial Mesenchymal Transition in Tumor Metastasis
2018 Standout
The past, present, and future of coral heat stress studies
2019
Myocarditis
2016
Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System?
2019 Standout
Cancer: Evolution Within a Lifetime
2014
Artificial intelligence in cancer imaging: Clinical challenges and applications
2019 Standout
Donor-dependent variations in hepatic differentiation from human-induced pluripotent stem cells
2012 StandoutNobel
Intratumor Heterogeneity: Evolution through Space and Time
2012
Wound Healing: A Cellular Perspective
2018 Standout
Innate Immunity Evasion by Enteroviruses: Insights into Virus-Host Interaction
2016
Deciphering intratumor heterogeneity and temporal acquisition of driver events to refine precision medicine
2014
Increased Replicative Fitness Can Lead to Decreased Drug Sensitivity of Hepatitis C Virus
2014 StandoutNobel
Internal Disequilibria and Phenotypic Diversification during Replication of Hepatitis C Virus in a Noncoevolving Cellular Environment
2017 StandoutNobel
Parallel evolution of tumour subclones mimics diversity between tumours
2013
Evaluation of antiviral activities of Houttuynia cordata Thunb. extract, quercetin, quercetrin and cinanserin on murine coronavirus and dengue virus infection
2015
Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19)
2020 Standout
Important Flavonoids and Their Role as a Therapeutic Agent
2020 Standout
Works of Bing‐Ching Ho being referenced
Pretreatment Epidermal Growth Factor Receptor ( EGFR ) T790M Mutation Predicts Shorter EGFR Tyrosine Kinase Inhibitor Response Duration in Patients With Non–Small-Cell Lung Cancer
2012
EGFR-activating mutations, DNA copy number abundance of ErbB family, and prognosis in lung adenocarcinoma
2016
ChemiRs: a web application for microRNAs and chemicals
2016
Identification of microRNAs regulated by activin A in human embryonic stem cells
2009
Inhibition of miR-146a prevents enterovirus-induced death by restoring the production of type I interferon
2014
Houttuynia cordata Targets the Beginning Stage of Herpes Simplex Virus Infection
2015
Enterovirus-Induced miR-141 Contributes to Shutoff of Host Protein Translation by Targeting the Translation Initiation Factor eIF4E
2011
Target identification of microRNAs expressed highly in human embryonic stem cells
2009